Skip to main content
OET ONLINE TRAINING @ $44

Sample OET writing ....



 I am writing to refer Mr. Billy. He is suffering from basal cell carcinoma of neck. He requires further care and support from your facility as he is due for discharge today.

 Mr billy admitted to our hospital on 21/06/2011 due to skin-related issues, and he has undergone skin biopsy for pathological studies, which confirmed his diagnosis / he has basal cell carcinoma. Therefore removal of basal cell carcinoma performed. As part of pain management, he commenced on panadene forte 500 mg. In general, he has no complication reported during hospitalization.

 Mr billy lives with his wife. He is a regular smoker and drinker for the past 30 years.

After discharge, please monitor him daily to find complications. Besides, he can continue medication one more week. In case of emergency, please contact his wife Jennifer, her contact details attached with this letter

Thank you for taking Mr.billy into your care. Please do not hesitate to contact me if you have any quires.

Labels:
Location: Toronto, ON, Canada

Comments

  1. Bibin EaloorApril 13, 2020 at 7:48 AM

    As a nurse looking OET Online for Nurses, I found this article very helpful.

    ReplyDelete
  2. Pamela WeberNovember 21, 2020 at 12:08 AM

    Great Article! I got too much information from this post. Thanks for sharing such a helpful article. Click here for more information about it

    ReplyDelete

Post a Comment

Popular posts from this blog

  OET SAMPLE LETTER - Robyn Harwood                            WINNER ONLINE OET I am writing to request a home visit for Ms. Harwood. She is diagnosed with right partial rotator cuff tear. She requires care and assistance from your facility.                                                                                                                   Or                                                                      ...
Post a Comment
Read more

Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

66  References Figure 1. Lipid Metabolism and Targets for Pharmacotherapy. In 1961, the investigators involved in the Framingham Heart Study identified serum cholesterol as one of the “factors of risk” for coronary heart disease. 1  Since then, numerous epidemiologic studies and randomized clinical trials have established that an elevated level of low-density lipoprotein (LDL) cholesterol is a major contributor to atherosclerotic cardiovascular disease. 2,3  As a consequence, the management of serum cholesterol levels has become a central objective in the effort to prevent cardiovascular events. The currently used therapies with demonstrated efficacy (see Table S1 in the  Supplementary Appendix , available with the full text of this article at NEJM.org) predominantly target the apolipoprotein B–associated lipoproteins reflected in levels of LDL cholesterol, non–high-density lipoprotein cholesterol (non-HDL cholesterol), and triglycerides ( Figure 1 ). Figur...
Post a Comment
Read more